Vivos Therapeutics (Vivos Therapeutics) Days Sales Outstanding : 6.04 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Vivos Therapeutics Days Sales Outstanding?

Vivos Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was $0.22 Mil. Vivos Therapeutics's Revenue for the three months ended in Dec. 2023 was $3.25 Mil. Hence, Vivos Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 6.04.

The historical rank and industry rank for Vivos Therapeutics's Days Sales Outstanding or its related term are showing as below:

VVOS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.12 Med: 25.98 Max: 57.27
Current: 8.12

During the past 6 years, Vivos Therapeutics's highest Days Sales Outstanding was 57.27. The lowest was 8.12. And the median was 25.98.

VVOS's Days Sales Outstanding is ranked better than
98.27% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 64.2 vs VVOS: 8.12

Vivos Therapeutics's Days Sales Outstanding declined from Dec. 2022 (15.28) to Dec. 2023 (6.04).

Vivos Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Vivos Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivos Therapeutics Days Sales Outstanding Chart

Vivos Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

23.48

32.15

28.47

18.91

8.71

Vivos Therapeutics Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															15.28	9.20	8.71	7.67	6.04

Competitive Comparison of Vivos Therapeutics's Days Sales Outstanding

For the Medical Devices subindustry, Vivos Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivos Therapeutics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vivos Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Vivos Therapeutics's Days Sales Outstanding falls into.

Vivos Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Vivos Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.457	+	0.202)	/	2 )	/	13.801	*	365
=	0.3295					/	13.801	*	365
=	8.71

Vivos Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.228	+	0.202)	/	2 )	/	3.248	*	365 / 4
=	0.215					/	3.248	*	365 / 4
=	6.04

Vivos Therapeutics (NAS:VVOS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Vivos Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Vivos Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivos Therapeutics (Vivos Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vivos Therapeutics Inc (NAS:VVOS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

7921 Southpark Plaza, Suite 210, Littleton, CO, USA, 80120

Website

https://www.vivos.com

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System.

Executives

Ronald Kirk Huntsman	director, 10 percent owner, officer: Chairman & CEO	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129
Bradford K. Amman	officer: Chief Financial Officer	6400 S. FIDDLER'S GREEN CIRCLE, SUITE 1970, GREENWOOD VILLAGE X1 80111
Leonard J Sokolow	director	REGATTA OFFICE PARK, WINDWARD THREE, 4TH FLOOR, WEST BAY ROAD, P.O. BOX 1114, GRAND CAYMAN E9 E9 KY11102
Matthew Thompson	director	2 MUSICK, IRVINE CA 92618
Anja B Krammer	director	C/O BIOPHARMX CORPORATION, 1505 ADAMS DRIVE, SUITE D, MENLO PARK CA 94025
Gurdev Dave Singh	director, 10 percent owner, officer: Chief Medical Officer	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129
Mark F. Lindsay	director	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129
Ralph Elias Green	director	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129